drugset / Trial / NCT00129155

MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies

NCT00129155

Phase 2 Unknown 30 enrolled Hospices Civils de Lyon
Non-randomizedSingle-groupOpen-labelTreatment

Summary

In this study, treosulfan is evaluated for conditioning in allogenic stem cell transplantation. The procedure and the follow-up are the same as in standard allogenic transplant. The donor is unrelated (identical HLA). The graft is haematological peripheral blood stem cell. The conditioning with reduced intensity is: fludarabine (from day -6 to day -2), treosulfan (from day -6 to day -4) and thymoglobuline (from day -2 to day -1).

Timeline

Start
2005-02
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Treosulfan Small molecule